Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Venture Life Group PLC (AIM: LON:VLG), a company specializing in self-care products, has announced impending board changes due to a potential conflict of interest identified by the current Non-Exec Chair, Mr. Paul McGreevy. The changes come as the company expands its presence in the vitamins and minerals market following the acquisition of Health & Her Limited in November 2024.
Mr. McGreevy, who also serves as CEO of Revive Active Limited, a business operating in similar markets, has decided to step down from his roles at Venture Life to avoid future conflicts of interest. His resignation will coincide with the announcement of the company’s annual results for the year ended December 31, 2024, expected in late April 2025. Mr. Mark Adams, a non-executive director since 2022, is set to succeed McGreevy as Chair of the Board.
Venture Life has initiated the process to find a new non-executive director who will also assume the role of Chair of the Audit Committee, a position that will be vacated by Adams as he transitions to his new role. The company will make a further announcement regarding this appointment in due course.
The Board expressed gratitude to Mr. McGreevy for his service since joining in 2022, acknowledging his contributions to the company’s growth and operational efficiency. CEO Jerry Randall praised McGreevy’s positive influence and mentorship, while McGreevy expressed his confidence in the company’s future and the Board’s ability to drive growth. McGreevy will continue to advise Venture Life on matters that do not pose a conflict of interest.
This announcement is based on a press release statement from Venture Life Group.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.